24/7 Market News Snapshot 18 July, 2025 – NanoVibronix, Inc. Common Stock (NASDAQ:NAOV)

July 18, 2025

DENVER, Colo., 18 July, 2025 (www.247marketnews.com) – (NASDAQ:NAOV) are discussed in this article.
NanoVibronix, Inc. (NAOV) has opened trading at $1.00, with its stock price currently at $1.025, reflecting an increase of approximately 1.49% from the previous close of $1.010. This positive trading momentum indicates strong buyer interest, supported by a trading volume of 8.66 million shares, suggesting a robust market activity that may sustain upward trends. Technical indicators are showing potential bullish signals, particularly with a resistance level around $1.05, inviting traders to monitor volume trends to gauge the possibility of further price increases.

In a strategic move to enhance its financial position and support its innovative medical technology solutions, the company has also announced a definitive agreement with an institutional investor to acquire 8,889 shares of Series H Convertible Preferred Stock, valued at $8,888,889. The Preferred Stock is set to convert to common stock at an initial price of $1.01 per share, reflecting the Nasdaq closing price prior to the agreement. The first closing is expected around July 21, 2025, contingent upon standard regulatory approvals.

Doron Besser, M.D., CEO of NanoVibronix, emphasized that this capital injection will empower the company to expand its reach in vital markets, enhance operational capabilities, and develop products that demonstrate significant growth potential and long-term shareholder value. The proceeds from this financing initiative will predominantly be allocated to redeem certain outstanding Series X Preferred Shares and meet broader working capital requirements.

NanoVibronix is also engaging Palladium Capital Group, LLC as its exclusive placement agent for this initiative. With a commitment to advancing non-invasive and minimally invasive healthcare solutions, the company is strategically positioned to make meaningful contributions to the medical technology field, thereby improving patient outcomes and bolstering its competitive edge in the industry.

Related news for (NAOV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.